Development of pH Neutral Ketamine ; Trials Progressing for Suicide Drug Treatment with Strong Q4 Results: NASDAQ: NRXP
Strong Q4 Results Propel NRx Pharmaceuticals' pH Neutral Ketamine Development Amid Approved Stock Dividend: NRXP NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) WILMINGTON, DELAWARE, UNITED STATES , April 15, 2024 /EINPresswire.com/ -- Successful …